Lantheus Holdings (LNTH) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Lantheus Holdings (LNTH) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | -11.41% |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | 8.48% |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | 27.10% |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | - |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | -5.63% |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | 13.12% |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | 11.74% |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | 15.13% |
| 10 | Lantheus Holdings | 78.78 Mn | -419.80 Mn | 230.92 Mn | 7.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.32% |
| Dec 31, 2025 | 10.24% |
| Sep 30, 2025 | 10.74% |
| Jun 30, 2025 | 9.85% |
| Mar 31, 2025 | 15.62% |
| Dec 31, 2024 | 14.83% |
| Sep 30, 2024 | 13.34% |
| Jun 30, 2024 | 10.10% |
| Mar 31, 2024 | 8.23% |
| Dec 31, 2023 | 6.87% |
| Sep 30, 2023 | 4.66% |
| Jun 30, 2023 | 1.88% |
| Mar 31, 2023 | 5.48% |
| Dec 31, 2022 | 1.60% |
| Sep 30, 2022 | 2.10% |
| Jun 30, 2022 | 1.71% |
| Mar 31, 2022 | 1.39% |
| Dec 31, 2021 | 2.67% |
| Sep 30, 2021 | 5.41% |
| Jun 30, 2021 | 6.97% |